Skip to content
Sign in
Artwork for Thinking Thoracic
Health & FitnessMedicineScience

Thinking Thoracic

thinkingthoracic

The Society of Thoracic Surgeon Thinking Thoracic podcast dives deep into the latest advancements and breakthroughs shaping the future of thoracic surgery. The podcast series is hosted by a dedicated team of STS member surgeons, including Dr. Hari Keshava, Dr. Jeff Yang, Dr. Erin Gillaspie, and Dr. Jane Yanagawa.

.

Play
Open in
  • 21 episodes
  • Avg 44 min
  • English

Episodes 21

NewestOldestLongest
All20Unplayed20In progress0Played0
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • #33
    Thursday · 31 min

    #27, S2 Choosing a CT Surgery Path

    What does the path to a career in cardiothoracic surgery look like today? Host Dr. Jane Yanagawa is joined by Dr. Varun Puri, Chief of Thoracic Surgery and CT Surgery Program Director at Washington University in St. Louis, to break down the evolving training pathways available to medical students and general surgery residents. They explore traditional 5+2/5+3 fellowships, fast-track 4+3 programs, and integrated I-6 tracks, highlighting key differences in clinical exposure, training timelines, board certification, and leadership development. The conversation also explores current match dynamics and common applicant misconceptions around applying to multiple tracks, while emphasizing the importance of early mentorship, scholarly research, and professional society resources such as TSMA, TSDA and TSRA in building a successful surgical career.

  • #32
    August 13 · 44 min

    #26, S2 The ABTS Playbook: Your Questions Answered

    In this episode of the STS Thinking Thoracic podcast, host Dr. Jane Yanagawa is joined by Dr. John Mitchell—Chief of Thoracic Surgery at the University of Colorado and incoming Chair of the American Board of Thoracic Surgery (ABTS)—to unpack critical updates from the board. Their discussion provides an inside look at how the ABTS operates, how surgeons can get involved, and key changes to initial and continuing certification pathways, including the recent transition from a 10-year to a 5-year certification cycle. Together, these updates are designed to help diplomates keep pace with modern clinical practice.

  • #31
    July 30 · 54 min

    #25, S2 Redefining Lymph Node Evaluation in Lung Cancer Surgery

    In this episode of the STS Thinking Thoracic podcast, host Dr. Jeff Yang is joined by thoracic surgeons Dr. Seth Krantz and Dr. Christopher Seder, along with Harvard medical student Alexandra Potter, to discuss three landmark studies using the STS General Thoracic Surgery Database that are reshaping how lymph node evaluation is performed in lung cancer surgery. The panel explores current guidelines, quality standards, and how more comprehensive nodal evaluation can improve staging accuracy while maintaining patient safety. The discussion highlights national trends in surgical quality, the importance of surgeon-pathologist collaboration, and the future of personalized lymph node evaluation, including the potential role of emerging technologies such as radiomics, genomic markers, and AI.

  • #30
    July 16 · 39 min

    Best of Lung Cancer Science 2026 - American Society of Clinical Oncology (ASCO)

    Jonathan Villena-Vargas, MD, sits down with Thinking Thoracic podcast host Erin Gillaspie, MD, to examine key findings from the American Society of Clinical Oncology (ASCO) Annual Meeting, including advances in targeted therapy, dual-pathway immunotherapy, artificial intelligence, and adaptive treatment strategies that are reshaping thoracic oncology.

  • #29
    July 9 · 45 min

    #24, S2 High Stakes in the Malignant Airway

    In this special joint episode of the STS Thinking Thoracic podcast and the American Association for Bronchology and Interventional Pulmonology (AABIP), Dr. Erin Gillaspie is joined by interventional pulmonologist Dr. Sameer Avasarala, of University Hospitals, and head and neck surgeon Dr. Britney Scott, of the CHI Health Clinic, to discuss the multidisciplinary management of malignant airway obstruction. The conversation emphasizes multidisciplinary collaboration among specialists, noting that treatment decisions depend not only on anatomy but also on patient-specific factors such as frailty, pulmonary function, and overall cardiopulmonary status. Using a top-to-bottom anatomic approach, the discussion explores management of tumors involving the upper trachea, mid-trachea, and carina, covering bronchoscopy, tumor debulking, stenting, tracheostomy, and surgical resection. They also discuss preoperative planning, postoperative airway care, and the value of multidisciplinary tumor boards and real-time collaboration.

  • #28
    June 18 · 23 min

    #23, S2 The Year's Most Important Thoracic Oncology Papers, Part 2

    In Part 2 of Thinking Thoracic's annual review of the year's most influential thoracic oncology research, Drs. Jeff Yang and Linda Martin examine practice-changing studies in perioperative care, lung cancer treatment, and multidisciplinary cancer management. The discussion covers emerging evidence on cryoanalgesia, preoperative fasting, targeted therapies for EGFR-mutated lung cancer, and other key clinical trials and consensus recommendations that are influencing patient care today.

  • #27
    June 18 · 47 min

    #22, S2 The Year's Most Important Thoracic Oncology Papers, Part 1

    In Part 1 of this special Thinking Thoracic episode, Dr. Jeff Yang welcomes Dr. Linda Martin for a discussion of groundbreaking research spanning immunotherapy, lung cancer epidemiology, and screening. Together, they explore emerging organ-preserving strategies for mismatch repair-deficient cancers, the growing population of patients with lung cancer who have never smoked, and new data highlighting opportunities to improve screening eligibility and uptake. Hear expert analysis of the studies shaping the future of thoracic oncology and what these findings mean for surgeons and patients alike.

  • #26
    June 10 · 38 min

    Best of Lung Cancer Science 2026 -- European Lung Cancer Congress (ELCC)

    Host Dr. Erin Gillaspie is back with a new season of the popular Best of Lung Cancer Science video podcast series. In this episode, featuring Dr. Jonathan Spicer, they break down key takeaways from the European Lung Cancer Congress, including evolving surgical approaches and how biology, AI, and real-world data are reshaping lung cancer care.

  • #25
    May 26 · 46 min

    #21, S2 Breaking the Stigma: Closing Gaps in Lung Cancer Care for Women

    In recognition of National Women’s Health Month, this episode of Thinking Thoracic analyzes the evolving landscape of female-specific lung cancer care. Co-hosts Dr. Erin Gillaspie and Dr. Jane Yanagawa sit down with guest Dr. Leah Backhus to discuss a critical disparity: lung cancer is the leading cause of cancer death among women, yet screening practices remain inequitable. This timely episode moves beyond smoking history to examine the rise of lung cancer in never-smokers and Asian women. From the "stigma" of a diagnosis to innovative solutions like co-scheduling screenings with mammograms, providing a powerful call to action for more inclusive, biomarker-driven care.

  • #24
    April 21 · 35 min

    #20, S2 Advancing ERAS and the Evolution of Minimally Invasive Thoracic Surgery

    In this episode of Thinking Thoracic, podcast hosts Hari Keshava, MD, and Erin Gillaspie, MD, talk with René Petersen, MD, of Copenhagen University Hospital, about the latest developments in Enhanced Recovery After Surgery (ERAS) protocols. As a longtime leader and pioneer in the field, Dr. Petersen shares insights from his extensive experience advancing recovery practices. The conversation covers the broader evolution of minimally invasive thoracic surgery, including video-assisted approaches, and how these developments inform patient selection for tubeless procedures.

  • #23
    March 30 · 40 min

    #19, S2 Breathing New Life into Emphysema Care

    n this episode of Thinking Thoracic, podcast hosts Hari Keshave, MD, and Erin Gillaspie, MD, talk with J. W. Awori Hayanga, MD, West Virginia University Medicine, about his recent study published in The Annals of Thoracic Surgery on surgical interventions for end-stage emphysema. The conversation highlights symptom burden, a multidisciplinary approach to treatment, and the latest data on lung volume reduction surgery. Article references: Hayanga JWA, Luo X, Reddy S, Mehaffey JH, Rothenberg P, Chauhan D, Rajjoub H, Mascio C, Baker N, Badhwar V, Lamb J, Toker A. Endobronchial Valve Therapy vs Lung Volume Reduction Surgery in the United States. Ann Thorac Surg. 2025 Nov;120(5):917-925. doi: 10.1016/j.athoracsur.2025.06.053. Epub 2025 Jul 19. PMID: 40691922; PMCID: PMC12542816 Hayanga JWA, Voppuru S, Bham N, Hansen A, Mehaffey JH, Rajjoub H, Reddy S, Badhwar V, Lamb J. Higher Costs and Lower Reimbursement of Endobronchial Valve Therapy vs Lung Volume Reduction Surgery in the United States. Ann Thorac Surg. 2026 Jan;121(1):174-180. doi: 10.1016/j.athoracsur.2025.09.033. Epub 2025 Nov 6. PMID: 41205846.

  • #22
    March 9 · 38 min

    #18, S2 New Advances in Thoracic Surgery at STS 2026

    In the season two premiere episode of Thinking Thoracic, cohosts Drs. Erin Gillaspie, Hari Keshava, Jeff Yang, and Jane Yanagawa review the latest thoracic surgery research presented at the 2026 STS Annual Meeting in New Orleans.

  • #21
    February 18 · 1 hr 11 min

    Best of Lung Cancer Science - European Society for Medical Oncology (ESMO)

    Jessica Donington, MD, and Christine Bestvina, MD, join Dr. Gillaspie to unpack key lung cancer advances from ESMO, including adjuvant ALK inhibition (ALINA, ELEVATE), perioperative immunotherapy (KEYNOTE-671), and the expanding neoadjuvant space in borderline resectable disease.

  • #17
    Dec 2, 2025 · 48 min

    #17, S2 The Future of Mesothelioma Treatment

    The latest episode of Thinking Thoracic dives into one of the most challenging diseases in thoracic oncology—malignant pleural mesothelioma. Host Erin Gillaspie, MD, speaks with Joshua Reuss, MD, a thoracic medical oncologist and clinical trials leader, about how immunotherapy, evolving surgical strategies, and global practice patterns are reshaping care for this rare cancer. The episode covers the impact of the Checkmate 743 trial, controversy surrounding the MARS-2 surgical study, promising results from neoadjuvant immunotherapy trials, and the critical need for collaboration and clinical trial enrollment to drive progress. Listen now to explore where mesothelioma research is headed and what it means for patient care.

  • #16
    Oct 30, 2025 · 42 min

    #16, S1 How the VERITAS Trial Has Transformed Lung Cancer Diagnosis

    In this episode of Thinking Thoracic, host Dr. Erin Gillaspie talks with Dr. Robert Lentz and Dr. Fabien Maldonado about the groundbreaking VERITAS trial, which is reshaping how clinicians diagnose lung cancer. Published in the New England Journal of Medicine, the VERITAS trial compared navigational bronchoscopy with CT-guided biopsy in a rigorous, randomized design, bringing much-needed evidence to interventional pulmonology. The discussion explores how the study was conceived, why robust device trials are vital to patient outcomes, and what the findings mean for the future of minimally invasive lung diagnostics.

  • #15
    Oct 8, 2025 · 1 hr 1 min

    #15, S1 A CT Surgeon’s Worth: Negotiation and Money Management

    The latest episode of Thinking Thoracic takes on a topic that’s on everyone’s minds: finances. Host Erin Gillaspie, MD, sits down with Lawrence Greiten, MD, and Josh Daily, MD, both from Arkansas Children’s Hospital, to discuss their recent paper examining financial decision-making in cardiothoracic surgery. From training pathways to compensation survey data, the conversation highlights how earnings and financial trade-offs shape career choices and negotiations. Tune in today.

  • #14
    Sep 16, 2025 · 1 hr 1 min

    #14, S1 Insights Into the Landmark CheckMate 816 Trial

    This latest episode of Thinking Thoracic, an STS podcast, features host Erin Gillaspie, MD, in conversation with Jonathan Spicer, MD, a leading thoracic oncologist and clinical trial investigator. The two dive into the landmark CheckMate 816 trial, which helped usher in a new era for immunotherapy in lung cancer treatment. Dr. Spicer shares insights on trial design, clinical outcomes, and what these findings mean for the future of thoracic surgery and oncology. Listen today.

Showing 1–20 of 21 episodes